Mansip, John Micheal T.

HRN: 29-02-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2026
CEFUROXIME 750MG (VIAL)
05/20/2026
05/27/2026
IV
250MG
Q8H
SCALD BURN GLUTEAL AREA ( ) ANST
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: